Vaccines — Revenue
Zoetis Vaccines — Revenue increased by 1.4% to $519.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from $447.00M to $519.00M. Over 4 years (FY 2021 to FY 2025), Vaccines — Revenue shows an upward trend with a 4.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful product adoption, effective market penetration, or increased demand for preventative animal healthcare, while a decrease may indicate competitive pressure or reduced disease prevalence.
Detailed definition
This metric represents the total net sales generated from the sale of biological preparations designed to provide immuni...
Peer comparison
Peers in the animal health and pharmaceutical sectors typically report this as a core product category revenue, often benchmarked against total segment growth rates and overall market expansion in veterinary medicine.
zts_segment_vaccines_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $417.00M | $421.00M | $422.00M | $405.00M | $446.00M | $449.00M | $418.00M | $429.00M | $430.00M | $449.00M | $463.00M | $452.00M | $445.00M | $468.00M | $462.00M | $447.00M | $504.00M | $496.00M | $512.00M | $519.00M |
| QoQ Change | — | +1.0% | +0.2% | -4.0% | +10.1% | +0.7% | -6.9% | +2.6% | +0.2% | +4.4% | +3.1% | -2.4% | -1.5% | +5.2% | -1.3% | -3.2% | +12.8% | -1.6% | +3.2% | +1.4% |
| YoY Change | — | — | — | — | +7.0% | +6.7% | -0.9% | +5.9% | -3.6% | +0.0% | +10.8% | +5.4% | +3.5% | +4.2% | -0.2% | -1.1% | +13.3% | +6.0% | +10.8% | +16.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Zoetis's vaccines — revenue?
- Zoetis (ZTS) reported vaccines — revenue of $519.00M in Q1 2026.
- How has Zoetis's vaccines — revenue changed year-over-year?
- Zoetis's vaccines — revenue increased by 16.1% year-over-year, from $447.00M to $519.00M.
- What is the long-term trend for Zoetis's vaccines — revenue?
- Over 4 years (2021 to 2025), Zoetis's vaccines — revenue has grown at a 4.0% compound annual growth rate (CAGR), from $1.67B to $1.96B.
- What does vaccines — revenue mean?
- The total revenue generated from the sale of animal vaccines.